Silver Oak Advisory Group’s AbbVie ABBV Stock Holding History

Silver Oak Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587K	Buy	2,333 +12	+0.5%	+$2.58K	0.23%	40
2026 Q1	$504K	Sell	2,321 -66	-3%	-$14.6K	0.22%	43
2025 Q4	$545K	Hold	2,387	–	–	0.25%	39
2025 Q3	$552K	Hold	2,387	–	–	0.25%	41
2025 Q2	$443K	Buy	2,387 +100	+4%	+$18.6K	0.21%	44
2025 Q1	$479K	Buy	2,287 +87	+4%	+$16.9K	0.25%	39
2024 Q4	$390K	Hold	2,200	–	–	0.21%	44
2024 Q3	$434K	Hold	2,200	–	–	0.22%	44
2024 Q2	$377K	Sell	2,200 -31	-1%	-$5.13K	0.21%	45
2024 Q1	$407K	Hold	2,231	–	–	0.23%	44
2023 Q4	$346K	Hold	2,231	–	–	0.2%	45
2023 Q3	$332K	Hold	2,231	–	–	0.22%	42
2023 Q2	$300K	Hold	2,231	–	–	0.2%	44
2023 Q1	$355K	Sell	2,231 -72	-3%	-$11K	0.24%	38
2022 Q4	$372K	Hold	2,303	–	–	0.26%	36
2022 Q3	$309K	Hold	2,303	–	–	0.23%	38
2022 Q2	$353K	Hold	2,303	–	–	0.25%	35
2022 Q1	$373K	Sell	2,303 -261	-10%	-$37.9K	0.24%	36
2021 Q4	$347K	Buy	+2,564	New	+$303K	0.22%	36

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Silver Oak Advisory Group's ABBV Position: Q2 2026 in Review

Silver Oak Advisory Group increased its AbbVie (ABBV) stake by 0.52% in Q2 2026, buying an estimated $2.58K and bringing the position to 2,333 shares worth $587K. The position accounts for 0.23% of the portfolio, ranked #40.

Silver Oak Advisory Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Silver Oak Advisory Group held 2,333 shares of AbbVie worth $587K as of Q2 2026.
Silver Oak Advisory Group bought 12 AbbVie shares in Q2 2026, an estimated $2.58K.
AbbVie made up 0.23% of Silver Oak Advisory Group's portfolio in Q2 2026, its #40 holding.
Silver Oak Advisory Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Silver Oak Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.